Skip to content

US · SEPN

Septerna Inc

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
South San Francisco, CA 94080

Price · as of 2026-09-04

$36.75

Market cap 1.75B

Price history

Weekly OHLC price history for SEPN, USD per share
WeekOpenHighLowCloseVolume
Oct 21, 2024 – Oct 25, 2024$23.50$25.62$20.90$21.40
Oct 28, 2024 – Nov 1, 2024$21.50$24.50$18.62$21.790
Nov 4, 2024 – Nov 8, 2024$22.19$26.34$21.48$25.910
Nov 11, 2024 – Nov 15, 2024$25.82$26.00$21.45$22.530
Nov 18, 2024 – Nov 22, 2024$22.37$25.32$20.68$22.000
Nov 25, 2024 – Nov 29, 2024$22.02$26.21$22.02$25.290
Dec 2, 2024 – Dec 6, 2024$25.35$27.47$24.37$25.750
Dec 9, 2024 – Dec 13, 2024$26.75$26.75$21.36$22.390
Dec 16, 2024 – Dec 20, 2024$21.95$24.69$20.61$24.280
Dec 23, 2024 – Dec 27, 2024$24.05$28.99$23.72$25.330
Dec 30, 2024 – Jan 3, 2025$25.00$25.27$20.61$23.690
Jan 6, 2025 – Jan 10, 2025$22.88$23.70$17.71$17.990
Jan 13, 2025 – Jan 17, 2025$18.14$18.16$15.86$16.890
Jan 20, 2025 – Jan 24, 2025$17.02$20.48$16.75$18.480
Jan 27, 2025 – Jan 31, 2025$19.02$19.02$15.27$16.910
Feb 3, 2025 – Feb 7, 2025$16.49$16.59$12.96$13.090
Feb 10, 2025 – Feb 14, 2025$12.90$13.19$10.34$12.960
Feb 17, 2025 – Feb 21, 2025$4.17$7.00$4.17$5.800
Feb 24, 2025 – Feb 28, 2025$6.23$6.65$5.47$6.470
Mar 3, 2025 – Mar 7, 2025$6.28$7.10$5.59$6.430
Mar 10, 2025 – Mar 14, 2025$6.31$6.92$5.75$6.300
Mar 17, 2025 – Mar 21, 2025$6.22$6.81$5.90$5.920
Mar 24, 2025 – Mar 28, 2025$5.94$6.44$5.90$6.100
Mar 31, 2025 – Apr 4, 2025$5.95$5.99$4.88$5.480
Apr 7, 2025 – Apr 11, 2025$5.25$5.81$4.66$5.720
Apr 14, 2025 – Apr 17, 2025$5.83$6.34$5.51$5.900
Apr 21, 2025 – Apr 25, 2025$5.81$6.53$5.73$6.460
Apr 28, 2025 – May 2, 2025$6.50$7.75$6.45$7.480
May 5, 2025 – May 9, 2025$7.43$7.58$6.41$6.690
May 12, 2025 – May 16, 2025$6.94$11.36$6.44$9.840
May 19, 2025 – May 23, 2025$9.71$10.18$8.86$9.190
May 26, 2025 – May 30, 2025$9.34$10.11$9.11$9.250
Jun 2, 2025 – Jun 6, 2025$9.33$10.98$9.28$10.210
Jun 9, 2025 – Jun 13, 2025$10.30$10.69$9.89$10.170
Jun 16, 2025 – Jun 20, 2025$10.16$10.75$9.85$10.470
Jun 23, 2025 – Jun 27, 2025$10.44$11.35$10.23$10.510
Jun 30, 2025 – Jul 3, 2025$10.54$11.49$10.30$11.370
Jul 7, 2025 – Jul 11, 2025$11.30$12.01$10.80$11.730
Jul 14, 2025 – Jul 18, 2025$11.80$13.00$11.52$12.550
Jul 21, 2025 – Jul 25, 2025$12.63$14.00$12.02$13.880
Jul 28, 2025 – Aug 1, 2025$14.02$14.21$11.80$12.210
Aug 4, 2025 – Aug 8, 2025$12.23$12.23$11.32$11.690
Aug 11, 2025 – Aug 15, 2025$11.69$12.10$10.62$11.720
Aug 18, 2025 – Aug 22, 2025$11.73$12.74$10.74$11.990
Aug 25, 2025 – Aug 29, 2025$12.01$12.87$11.70$12.100
Sep 1, 2025 – Sep 5, 2025$12.08$14.62$11.98$14.430
Sep 8, 2025 – Sep 12, 2025$14.46$15.50$13.67$14.280
Sep 15, 2025 – Sep 19, 2025$14.21$16.12$14.00$15.700
Sep 22, 2025 – Sep 26, 2025$15.65$17.64$15.41$17.450
Sep 29, 2025 – Oct 3, 2025$17.60$20.93$17.33$20.680
Oct 6, 2025 – Oct 10, 2025$20.68$23.61$20.17$23.070
Oct 13, 2025 – Oct 17, 2025$23.07$24.92$21.31$22.060
Oct 20, 2025 – Oct 24, 2025$22.36$22.93$20.82$21.670
Oct 27, 2025 – Oct 31, 2025$22.01$23.45$20.03$20.600
Nov 3, 2025 – Nov 7, 2025$20.42$20.71$17.55$18.510
Nov 10, 2025 – Nov 14, 2025$18.79$23.99$17.98$23.270
Nov 17, 2025 – Nov 21, 2025$22.68$26.26$21.31$25.560
Nov 24, 2025 – Nov 28, 2025$26.28$29.74$26.28$29.020
Dec 1, 2025 – Dec 5, 2025$28.81$29.14$25.46$26.760
Dec 8, 2025 – Dec 12, 2025$27.14$27.49$24.63$25.440
Dec 15, 2025 – Dec 19, 2025$25.70$30.50$25.40$29.580
Dec 22, 2025 – Dec 26, 2025$29.65$29.88$27.93$28.620
Dec 29, 2025 – Jan 2, 2026$28.31$29.23$27.50$27.980
Jan 5, 2026 – Jan 9, 2026$28.47$28.47$25.24$25.300
Jan 12, 2026 – Jan 16, 2026$25.49$28.15$24.44$26.070
Jan 19, 2026 – Jan 23, 2026$26.37$27.95$25.35$25.770
Jan 26, 2026 – Jan 30, 2026$25.72$26.60$23.23$23.340
Feb 2, 2026 – Feb 6, 2026$23.34$25.92$23.02$25.410
Feb 9, 2026 – Feb 13, 2026$25.47$27.64$24.98$27.500
Feb 16, 2026 – Feb 20, 2026$27.60$31.37$25.49$27.280
Feb 23, 2026 – Feb 27, 2026$27.30$32.63$26.84$29.020
Mar 2, 2026 – Mar 6, 2026$28.11$29.50$25.98$28.780
Mar 9, 2026 – Mar 13, 2026$28.79$30.00$24.96$25.140
Mar 16, 2026 – Mar 20, 2026$25.43$27.00$23.35$24.180
Mar 23, 2026 – Mar 27, 2026$24.63$25.33$22.97$23.870
Mar 30, 2026 – Apr 2, 2026$23.95$25.29$22.89$25.180
Apr 6, 2026 – Apr 10, 2026$24.88$25.83$22.97$23.090
Apr 13, 2026 – Apr 17, 2026$23.00$26.85$22.83$26.130
Apr 20, 2026 – Apr 24, 2026$25.95$27.30$24.49$24.670
Apr 27, 2026 – May 1, 2026$24.60$25.86$22.78$23.610
May 4, 2026 – May 8, 2026$23.52$25.25$23.29$23.870
May 11, 2026 – May 15, 2026$23.87$28.81$23.50$26.950
May 18, 2026 – May 22, 2026$27.08$29.89$25.79$28.360
May 25, 2026 – May 29, 2026$28.49$31.60$27.66$30.200
Jun 1, 2026 – Jun 5, 2026$29.59$31.79$27.08$31.150
Jun 8, 2026 – Jun 12, 2026$31.97$36.26$30.05$35.950
Jun 15, 2026 – Jun 18, 2026$36.27$37.32$33.88$36.170
Jun 22, 2026 – Jun 26, 2026$36.46$37.99$34.23$37.340
Jun 29, 2026 – Jul 2, 2026$35.18$35.99$32.00$34.000
Jul 6, 2026 – Jul 10, 2026$33.38$38.04$32.91$35.930
Jul 13, 2026 – Jul 17, 2026$35.64$36.01$30.55$33.400
Jul 20, 2026 – Jul 24, 2026$33.35$35.11$31.85$33.100
Jul 27, 2026 – Jul 31, 2026$33.25$35.82$32.85$34.450
Aug 3, 2026 – Aug 7, 2026$34.45$40.65$33.19$38.830
Aug 10, 2026 – Aug 14, 2026$38.56$51.10$38.05$44.500
Aug 17, 2026 – Aug 21, 2026$44.01$45.41$39.95$40.000
Aug 24, 2026 – Aug 28, 2026$39.76$41.85$38.74$38.910
Aug 31, 2026 – Sep 4, 2026$38.71$39.10$36.46$36.750

Valuation

MetricValueUpside
IC Value$8,348.79+22,618%
P/E-22.76
P/B2.91
P/S24.21
EV/EBITDA-15.77
PEG
P/TBV2.91

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for SEPN, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024$6.43$78.59
2025$25.14$362.54

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Septerna Inc

        Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.

        CEO
        Jeffrey T. Finer
        Employees
        130
        Beta
        2.28

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for SEPN: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        SEPNSepterna Inc$38.831.75B$362.54+834%-22.762.9124.21-15.772.91100.00%-175.83%-106.37%-12.19%-148.17%-9.29%0.064.734.662.05-43.01%4174.51%-257.63%9.86%1.27201.12%0.00%0.00%0.00%-9.226.7916.223.01
        ABUSArbutus Biopharma Corp$4.62912.62M$20.85+351%-24.3610.6657.96-22.0610.6697.42%-192.08%-237.88%-38.52%181.27%-29.60%0.05-278.8815.7315.520.42-55.26%128.21%-39.05%-4.86%-6.60265.61%0.00%0.00%0.00%-26.95-18.3951.767.05
        BCAXBicara Therapeutics Inc. …$25.891.42B-7.612.61-4.62-7.492.610.00%0.00%0.00%-30.88%3561.95%-27.58%0.0014.5814.330.69101.60%43.16%-10.21%-3.692451.96%0.00%0.00%0.00%-4.09-5.9420.05
        EYPTEyePoint Pharmaceuticals,…$12.251.03B$11.09-9%-4.173.1630.82-2.98-11.383.1693.41%-775.98%-739.42%-72.19%-4742.07%-59.29%0.077376.798.888.280.3436.64%-27.50%86.82%-25.17%-6.49-4741.21%0.00%0.00%0.12%-2.81-2.8121.794.61
        FTREFortrea Holdings Inc.$19.051.81B$8.22-57%-0.831.450.30-2.16-0.42-0.8015.63%-1.12%-36.21%-102.41%-1.55%-31.33%1.98-0.330.980.87-1.16194.55%1.00%-62.79%10.84%0.124.47%0.00%0.00%17.02%-57.3819.880.640.47
        KURAKura Oncology, Inc.$9.20816.72M$28.68+212%-2.724.3611.24-0.40-4.744.3699.92%-449.94%-412.95%-94.82%78.88%-37.19%0.12-200.816.065.810.4757.43%25.24%-152.82%-9.32%-0.5518.37%0.00%0.00%0.00%-0.37-1.581.65-1.72
        MRVIMaravai LifeSciences Hold…$6.41930.06M$46.68+628%-3.422.102.41-1.80-6.5117.98%-3.63%-70.41%-48.64%-3.22%-14.70%0.17-0.256.605.401.23-13.33%-28.34%218.67%-15.83%-1.28-34.44%0.00%0.00%52.73%-39.41-3.751.431.30
        NRIXNurix Therapeutics, Inc.$25.122.61B$13.15-48%-5.522.7117.39-3.77-93.552.7177.55%-340.16%-314.90%-49.63%1083.07%-38.96%0.107.026.860.785.90%53.95%44.88%-18.04%-2.88998.91%0.00%0.00%7.50%-3.23-3.5010.993.48
        PRMEPrime Medicine, Inc.$3.08556.3M$13.65+343%-2.704.49117.22-2.464.49-58.05%-4498.06%-4342.44%-146.81%-660.21%-62.83%0.964.844.74-0.27-18.26%55.28%28.38%-30.77%-4.34-529.49%0.00%0.00%0.00%-2.31-2.88104.00-3.65
        PROKProKidney Corp.$1.67247.44M$72.34+4,231%-1.99-0.30337.48-0.24-0.30100.00%-18477.83%-7725.20%15.11%12.56%-39.04%0.00-41251.759.138.820.72-16.13%1075.00%-13.18%-44.90%-3.9110.30%0.00%0.00%2.86%-0.21-0.2639.63-0.83
        TNGXTango Therapeutics, Inc.$28.793.58B$16.80-42%-19.785.8132.21-17.125.8196.34%-178.39%-162.85%-37.23%-1513.72%-28.41%0.1016.3215.830.79-26.89%48.29%5.81%-6.96%-6.41-1903.35%0.00%0.00%2.27%-15.28-12.1527.2521.08

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($8,348.79 ÷ $36.75) − 1 = +22,617.8% (IC, example).